{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:01:37Z","timestamp":1793394097758,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Natural Science Foundation of Guangdong Province","award":["2021A1515011320"],"award-info":[{"award-number":["2021A1515011320"]}]},{"name":"Major scientific research project of basic and applied basic research in Guangdong Province","award":["B2022151523007"],"award-info":[{"award-number":["B2022151523007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12015-025-10923-7","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:26:55Z","timestamp":1750660015000},"page":"1750-1759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up"],"prefix":"10.1007","volume":"21","author":[{"given":"Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent M.","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Pinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hershkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"10923_CR1","doi-asserted-by":"publisher","first-page":"1235937","DOI":"10.3389\/fimmu.2023.1235937","volume":"14","author":"JA \u00c1lvarez G\u00f3mez","year":"2023","unstructured":"\u00c1lvarez G\u00f3mez, J. A., Salazar-Camarena, D. C., Rom\u00e1n-Fern\u00e1ndez, I. V., Ortiz-Lazareno, P. C., Cruz, A., Mu\u00f1oz-Valle, J. F., Mar\u00edn-Rosales, M., Espinoza-Garc\u00eda, N., Sagrero-Fabela, N., & Palafox-S\u00e1nchez, C. A. (2023). BAFF system expression in double negative 2, activated Na\u00efve and activated memory B cells in systemic lupus erythematosus. Frontiers in Immunology, 14, 1235937. https:\/\/doi.org\/10.3389\/fimmu.2023.1235937","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10923_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/leu.2017.302","volume":"32","author":"KH Chen","year":"2018","unstructured":"Chen, K. H., Wada, M., Pinz, K. G., Liu, H., Shuai, X., Chen, X., Yan, L. E., Petrov, J. C., Salman, H., Senzel, L., Leung, E. L. H., Jiang, X., & Ma, Y. (2018). A compound chimeric antigen receptor strategy for targeting multiple myeloma. Leukemia, 32(2), 402\u2013412. https:\/\/doi.org\/10.1038\/leu.2017.302","journal-title":"Leukemia"},{"issue":"1","key":"10923_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000013557","volume":"20","author":"HJ Chin","year":"2000","unstructured":"Chin, H. J., Ahn, C., Lim, C. S., Chung, H. K., Lee, J. G., Song, Y. W., Lee, H. S., Han, J. S., Kim, S., & Lee, J. S. (2000). Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. American Journal of Nephrology, 20(1), 57\u201363. https:\/\/doi.org\/10.1159\/000013557","journal-title":"American Journal of Nephrology"},{"issue":"3","key":"10923_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.12865\/chsj.41.03.13","volume":"41","author":"C Cirstea","year":"2015","unstructured":"Cirstea, C., Barbulescu, A. L., Stoica, L. E., Vreju, F. A., & Ciurea, P. L. (2015). Overlap Syndrome-Systemic sclerosis, systemic lupus erythematosus and Dermatomyositis - Case report. Current Health Sciences Journal,41(3), 269\u2013273. https:\/\/doi.org\/10.12865\/chsj.41.03.13","journal-title":"Current Health Sciences Journal"},{"issue":"2","key":"10923_CR5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s12015-020-10092-9","volume":"17","author":"J Feng","year":"2021","unstructured":"Feng, J., Xu, H., Cinquina, A., Wu, Z., Chen, Q., Zhang, P., Wang, X., Shan, H., Xu, L., Zhang, Q., Sun, L., Zhang, W., Pinz, K. G., Wada, M., Jiang, X., Hanes, W. M., Ma, Y., & Zhang, H. (2021). Treatment of aggressive T cell lymphoblastic lymphoma\/leukemia using Anti-CD5 CAR T cells. Stem Cell Reviews and Reports,17(2), 652\u2013661. https:\/\/doi.org\/10.1007\/s12015-020-10092-9","journal-title":"Stem Cell Reviews and Reports"},{"key":"10923_CR6","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.eclinm.2024.102476","volume":"69","author":"R Greco","year":"2024","unstructured":"Greco, R., Alexander, T., Del Papa, N., M\u00fcller, F., Saccardi, R., Sanchez-Guijo, F., Schett, G., Sharrack, B., Snowden, J. A., Tarte, K., Onida, F., S\u00e1nchez-Ortega, I., Burman, J., Castilla Llorente, C., Cervera, R., Ciceri, F., Doria, A., Henes, J., Lindsay, J., Mackensen, A., Muraro, P. A., Ricart, E., Rovira, M., Zuckerman, T., Yakoub-Agha, I., & Farge, D. (2024). Innovative cellular therapies for autoimmune diseases: Expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. EClinicalMedicine, 69, 102476. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102476","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10923_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneph.2016.20","volume":"12","author":"F Hiepe","year":"2016","unstructured":"Hiepe, F., & Radbruch, A. (2016). Plasma cells as an innovative target in autoimmune disease with renal manifestations. Nature Reviews Nephrology, 12(4), 232\u2013240. https:\/\/doi.org\/10.1038\/nrneph.2016.20","journal-title":"Nature Reviews Nephrology"},{"issue":"3","key":"10923_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00281-014-0431-y","volume":"36","author":"JC Jennette","year":"2014","unstructured":"Jennette, J. C., & Falk, R. J. (2014). B cell-mediated pathogenesis of ANCA-mediated vasculitis. Seminars in Immunopathology, 36(3), 327\u2013338. https:\/\/doi.org\/10.1007\/s00281-014-0431-y","journal-title":"Seminars in Immunopathology"},{"issue":"2","key":"10923_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee, D. W., Gardner, R., Porter, D. L., Louis, C. U., Ahmed, N., Jensen, M., Grupp, S. A., & Mackall, C. L. (2014). Current concepts in the diagnosis and management of cytokine release syndrome. Blood, 124(2), 188\u2013195. https:\/\/doi.org\/10.1182\/blood-2014-05-552729","journal-title":"Blood"},{"issue":"Suppl 1","key":"10923_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/annrheumdis-2020-eular.4065","volume":"79","author":"F Liu","year":"2020","unstructured":"Liu, F., Zhang, H., Wang, X., Feng, J., Cao, Y., Su, Y., Wada, M., Ma, Y., & Ma, Y. (2020). THU0036\u2005FIRST-IN-HUMAN TRIAL OF BCMA-CD19 COMPOUND CAR IN THE TREATMENT OF AUTOANTIBODY MEDIATED DISORDERS. Annals of the Rheumatic Diseases, 79(Suppl 1), 231\u2013231. https:\/\/doi.org\/10.1136\/annrheumdis-2020-eular.4065","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"Supplement_1","key":"10923_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/blood-2019-122964","volume":"134","author":"F Liu","year":"2019","unstructured":"Liu, F., Zhang, H., Wang, X., Xiong, Y., Cao, Y., Su, Y., Yi, H., Feng, J., Zhang, W., Ma, Y., Wada, M., & Ma, Y. (2019). First-in-Human trial of Bcma-CD19 compound CAR with remarkable Donor-Specific antibody reduction. Blood, 134(Supplement_1), 38\u201338. https:\/\/doi.org\/10.1182\/blood-2019-122964","journal-title":"Blood"},{"issue":"10","key":"10923_CR12","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen, A., Muller, F., Mougiakakos, D., Boltz, S., Wilhelm, A., Aigner, M., Volkl, S., Simon, D., Kleyer, A., Munoz, L., Kretschmann, S., Kharboutli, S., Gary, R., Reimann, H., Rosler, W., Uderhardt, S., Bang, H., Herrmann, M., Ekici, A. B., Buettner, C., Habenicht, K. M., Winkler, T. H., Kronke, G., & Schett, G. (2022). Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nature Medicine, 28(10), 2124\u20132132. https:\/\/doi.org\/10.1038\/s41591-022-02017-5","journal-title":"Nature Medicine"},{"key":"10923_CR13","doi-asserted-by":"publisher","unstructured":"Merino-Vico, A., van Hamburg, J. P., & Tas, S. W.\u00a0(2021). B lineage cells in ANCA-Associated vasculitis. International Journal of Molecular Sciences, 23(1). https:\/\/doi.org\/10.3390\/ijms23010387","DOI":"10.3390\/ijms23010387"},{"issue":"8","key":"10923_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F M\u00fcller","year":"2024","unstructured":"M\u00fcller, F., Taubmann, J., Bucci, L., Wilhelm, A., Bergmann, C., V\u00f6lkl, S., Aigner, M., Rothe, T., Minopoulou, I., Tur, C., Knitza, J., Kharboutli, S., Kretschmann, S., Vasova, I., Spoerl, S., Reimann, H., Munoz, L., Gerlach, R. G., Sch\u00e4fer, S., Grieshaber-Bouyer, R., Korganow, A. S., Farge-Bancel, D., Mougiakakos, D., Bozec, A., Winkler, T., Kr\u00f6nke, G., Mackensen, A., & Schett, G. (2024). CD19 CAR T-Cell therapy in autoimmune Disease - A case series with Follow-up. New England Journal of Medicine, 390(8), 687\u2013700. https:\/\/doi.org\/10.1056\/NEJMoa2308917","journal-title":"New England Journal of Medicine"},{"key":"10923_CR15","doi-asserted-by":"publisher","first-page":"101104","DOI":"10.1016\/j.omtm.2023.08.023","volume":"31","author":"D Nunez","year":"2023","unstructured":"Nunez, D., Patel, D., Volkov, J., Wong, S., Vorndran, Z., M\u00fcller, F., Aigner, M., V\u00f6lkl, S., Mackensen, A., Schett, G., & Basu, S. (2023). Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy. Molecular Therapy.\u00a0Methods\u00a0& Clinical Development,31, 101104. https:\/\/doi.org\/10.1016\/j.omtm.2023.08.023","journal-title":"Molecular Therapy.\u00a0Methods\u00a0& Clinical Development"},{"key":"10923_CR16","doi-asserted-by":"publisher","first-page":"952304","DOI":"10.3389\/fmed.2022.952304","volume":"9","author":"I Parodis","year":"2022","unstructured":"Parodis, I., Gatto, M., & Sj\u00f6wall, C. (2022). B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools. Front Med (Lausanne), 9, 952304. https:\/\/doi.org\/10.3389\/fmed.2022.952304","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10923_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/leu.2015.311","volume":"30","author":"K Pinz","year":"2016","unstructured":"Pinz, K., Liu, H., Golightly, M., Jares, A., Lan, F., Zieve, G. W., Hagag, N., Schuster, M., Firor, A. E., Jiang, X., & Ma, Y. (2016). Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells. Leukemia, 30(3), 701\u2013707. https:\/\/doi.org\/10.1038\/leu.2015.311","journal-title":"Leukemia"},{"key":"10923_CR18","doi-asserted-by":"publisher","unstructured":"van Vollenhoven, R. F., Bertsias, G., Doria, A., Isenberg, D., Morand, E., Petri, M. A., Pons-Estel, B. A., Rahman, A., Ugarte-Gil, M. F., Voskuyl, A., Arnaud, L., Bruce, I. N., Cervera, R., Costedoat-Chalumeau, N., Gordon, C., Houssiau, F. A., Mosca, M., Schneider, M., Ward, M. M., Alarcon, G., Aringer, M., Askenase, A., Bae, S. C., Bootsma, H., Boumpas, D. T., Brunner, H., Clarke, A. E., Coney, C., Czirj\u00e1k, L., D\u00f6rner, T., Faria, R., Fischer, R., Fritsch-Stork, R., Inanc, M., Jacobsen, S., Jayne, D., Kuhn, A., van Leeuw, B., Limper, M., Mariette, X., Navarra, S., Nikpour, M., Olesinska, M. H., Pons-Estel, G., Romero-Diaz, J., Rubio, B., Schoenfeld, Y., Bonf\u00e1, E., Smolen, J., Teng, Y. K. O., Tincani, A., Tsang, A. S. M., Vasconcelos, C., Voss, A., Werth, V. P., Zakharhova, E., & Aranow, C. (2021). 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Science & Medicine, 8(1). https:\/\/doi.org\/10.1136\/lupus-2021-000538","DOI":"10.1136\/lupus-2021-000538"},{"issue":"2","key":"10923_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12015-019-09937-9","volume":"16","author":"M Wada","year":"2020","unstructured":"Wada, M., Zhang, H., Fang, L., Feng, J., Tse, C. O., Zhang, W., Chen, Q., Sha, S., Cao, Y., Chen, K. H., Pinz, K. G., Chen, X., Fan, X. X., Jiang, X., & Ma, Y. (2020). Characterization of an Anti-CD5 directed CAR T-Cell against T-Cell malignancies. Stem Cell Reviews and Reports,16(2), 369\u2013384. https:\/\/doi.org\/10.1007\/s12015-019-09937-9","journal-title":"Stem Cell Reviews and Reports"},{"issue":"4","key":"10923_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/bs9.0000000000000173","volume":"5","author":"JY Wang","year":"2023","unstructured":"Wang, J. Y., & Wang, L. (2023). CAR-T cell therapy: Where are we now, and where are we heading? Blood Science,5(4), 237\u2013248. https:\/\/doi.org\/10.1097\/bs9.0000000000000173","journal-title":"Blood Science"},{"issue":"10","key":"10923_CR21","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/ard-2024-225785","volume":"83","author":"W Wang","year":"2024","unstructured":"Wang, W., He, S., Zhang, W., Zhang, H., DeStefano, V. M., Wada, M., Pinz, K., Deener, G., Shah, D., Hagag, N., Wang, M., Hong, M., Zeng, R., Lan, T., Ma, Y., Li, F., Liang, Y., Guo, Z., Zou, C., Wang, M., Ding, L., Ma, Y., & Yuan, Y. (2024). BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: A phase 1 open-label clinical trial. Annals of the Rheumatic Diseases, 83(10), 1304\u20131314. https:\/\/doi.org\/10.1136\/ard-2024-225785","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10923_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12015-019-09948-6","volume":"16","author":"LE Yan","year":"2020","unstructured":"Yan, L. E., Zhang, H., Wada, M., Fang, L., Feng, J., Zhang, W., Chen, Q., Cao, Y., Pinz, K. G., Chen, K. H., Petrov, J. C., Chen, X., Leung, L. H., Fan, X. X., Senzel, L., Jiang, X., Ma, Y., & Tse, W. (2020). Targeting two antigens associated with B-ALL with CD19-CD123 compound Car T cell therapy. Stem Cell Reviews and Reports,16(2), 385\u2013396. https:\/\/doi.org\/10.1007\/s12015-019-09948-6","journal-title":"Stem Cell Reviews and Reports"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10923-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-10923-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10923-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T05:29:45Z","timestamp":1755235785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-10923-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10923"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-10923-7","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"11 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves human participants and was approved by the medical ethics committee (protocol number: K2022-294-3). Participants gave informed consent to participate in the study before taking part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}